Trial
NCT05839119
Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Brown University
Collaborators
Legorreta Cancer Center at Brown University; Lifespan; Cures Within Reach
Condition
Urothelial Carcinoma Bladder
Intervention
Degarelix
Why stopped
Principal Investigator left institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-02